Georgia approves HMO fee to help fund state Medicaid program

NewsGuard 100/100 Score

The Georgia Department of Community Health board on Thursday approved a plan to charge commercial HMOs the same fee as managed care companies that operate the state's Medicaid program in an effort to make up for a 5% reduction in program funding, the Savannah Morning News reports.

The fees are used to draw down federal match funds that are then combined to pay Medicaid managed care plans.

Community Health Commissioner Rhonda Medows said that the changes are required by new federal rules and that the decision to delay, rather than revoke, an increase in doctor and hospital reimbursements to July 1, 2009, might give hospitals enough reason to avoid layoffs and other drastic measures.

However, Jimmy Lewis -- CEO of HomeTown Health, an organization of small and rural hospitals -- said, "We may have riled a giant, the likes of which we can't imagine," noting that private insurers could increase premiums and renegotiate contracts with health providers. (Savannah Morning News, 8/28).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment